In album: My Videos
Millions of guys have tried using Cialis, Viagra or Levitra from the moment they were first offered the marketplace. However, few of these users, if any,acknowledged the danger of acquiring skin cancer as a result of that usage. A relatively new study published in the Journal of the American Medical Association (JAMA) discovered that males who used these drugs were associated with an increased threat of acquiring melanoma, despite accounting for other risks presented. This research study involved more than 20,000 males throughout a period of ten years and discovered a near doubling of relative threat as compared with non-users. Due to the mechanism of how the drug works, Levitra and Cialis are believed to expose users to the precise threats as Viagra in terms of increased vulnerability to cancer malignancy. They do so by preventing the phosphodiesterase 5 (PDE5). Speculative research studies have shown that this consequently enhances tumor cell invasiveness. Due to the fact that it develops faster than other types of skin cancer and cancer spreads to other body parts, melanoma is often described as the most dangerous kind of skin cancer. But if treated early, melanoma can be curable. Nevertheless, if left neglected, melanoma can easily lead to death. Specifically, the following might indicate melanoma: a small, dark, multicolored portion of skin with uneven borders that may also bleed and scab; a cluster of glossy, hard, black or brown bumps; or moles larger than a pencil’s eraser
The lawyers and staff at the O'Brien Firm have constantly taken great pride in their professional skills and the private support they offer their clients throughout these hard times. If you have acquired melanoma and you presume that it might be the result of the use of Cialis or Viagra, do not think twice about having to request caring and expert legal assistance. The lawyers at The O'Brien Firm will assist you in gathering medical records, providing your claim, and acquiring the settlement that you are entitled to.
Please login to add comments!